Everolimus/chemo-radiation fails to Improve progression-free survival in newly diagnosed glioblastoma

Adding everolimus (Afinitor) to chemo-radiation did not have a significant treatment effect for patients with newly diagnosed glioblastoma , according to results from the phase II NRG Oncology RTOG 0913 trial.
Targeted Oncology